191 related articles for article (PubMed ID: 2073222)
1. A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders.
Newburn GM; Fraser AR; Menkes DB; Mullen PE
Aust N Z J Psychiatry; 1990 Dec; 24(4):475-9. PubMed ID: 2073222
[TBL] [Abstract][Full Text] [Related]
2. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
[TBL] [Abstract][Full Text] [Related]
3. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium.
Beckers G; Vereecken A; de Bleeker E; Jaunes C; Sieben G; Faidherbe J; Wolfrum C; Berger M; Hellstern K; Ward J
Acta Psychiatr Scand Suppl; 1990; 360():52-3. PubMed ID: 2248072
[TBL] [Abstract][Full Text] [Related]
4. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
Evans L; George T; O'Sullivan B; Mitchell P; Johnson G; Adena M
Aust N Z J Psychiatry; 1992 Sep; 26(3):454-8. PubMed ID: 1417632
[TBL] [Abstract][Full Text] [Related]
5. A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study.
Bakish D; Bradwejn J; Nair N; McClure J; Remick R; Bulger L
Psychopharmacology (Berl); 1992; 106 Suppl():S98-101. PubMed ID: 1546154
[TBL] [Abstract][Full Text] [Related]
6. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
Bizière K; Berger M
Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
[TBL] [Abstract][Full Text] [Related]
8. A controlled study of a specific MAO A reversible inhibitor (R011-1163) and amitriptyline in depressive illness.
Norman TR; Ames D; Burrows GD; Davies B
J Affect Disord; 1985; 8(1):29-35. PubMed ID: 3156909
[TBL] [Abstract][Full Text] [Related]
9. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide, imipramine and placebo in the treatment of major depression.
Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide (Ro 11-1163) versus tranylcypromine in the treatment of endogenous depression.
Gabelic I; Kuhn B
Acta Psychiatr Scand Suppl; 1990; 360():63. PubMed ID: 2248076
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
Versiani M; Nardi AE; Figueira IL; Stabl M
Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
[TBL] [Abstract][Full Text] [Related]
13. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Lecrubier Y; Guelfi JD
Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of moclobemide and tranylcypromine in depression.
Heinze G; Rossel L; Gabelic I; Galeano-Munoz J; Stabl M; Allen SR
Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
[TBL] [Abstract][Full Text] [Related]
16. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
Tiller JW; Maguire KP; Davies BM
Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
[TBL] [Abstract][Full Text] [Related]
19. Moclobemide versus tranylcypromine in the treatment of depression.
Rossel L; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
[TBL] [Abstract][Full Text] [Related]
20. Thyroid functioning during treatment for depression.
Kusalic M; Engelsmann F; Bradwejn J
J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
